Performance of tacrolimus in hospitalized patients with steroid-refractory acute severe ulcerative colitis

Updated S3-Guideline Ulcerative Colitis. German Society for Digestive and Metabolic Diseases (DGVS)

(2019) et al.   ZEITSCHRIFT FUR GASTROENTEROLOGIE

Antibiotics in IBD: Still a Role in the Biological Era?

(2018) Oren Ledder et al.   INFLAMMATORY BOWEL DISEASES

Efficacy and Safety of Induction Therapy With Calcineurin Inhibitors in Combination with Vedolizumab in Patients With Refractory Ulcerative Colitis

(2018) Gauthier Pellet et al.   Clinical Gastroenterology and Hepatology

Long-term outcome of patients with steroid-refractory acute severe UC treated with ciclosporin or infliximab

(2017) D Laharie et al.   GUT

Third European Evidence-based Consensus on Diagnosis and Management of Ulcerative Colitis. Part 2: Current Management

(2017) Marcus Harbord et al.   Journal of Crohns & Colitis

Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies

(2017) Siew C Ng et al.   LANCET

Tacrolimus vs. anti-tumour necrosis factor agents for moderately to severely active ulcerative colitis: a retrospective observational study

(2016) T. Yamamoto et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Long-term Outcomes in Steroid-refractory Ulcerative Colitis Treated with Tacrolimus Alone or in Combination with Purine Analogues

(2015) K. J. Schmidt et al.   Journal of Crohns & Colitis

Efficacy and Safety of Tacrolimus Therapy for Active Ulcerative Colitis; A Systematic Review and Meta-analysis

(2015) Yuga Komaki et al.   Journal of Crohns & Colitis

Effects of oral tacrolimus as a rapid induction therapy in ulcerative colitis

(2015) Ken Kawakami   WORLD JOURNAL OF GASTROENTEROLOGY

Combination of oral antibiotics may be effective in severe pediatric ulcerative colitis: A preliminary report

(2014) Dan Turner et al.   Journal of Crohns & Colitis

Double-blind, placebo-controlled trial of oral tacrolimus (FK506) in the management of hospitalized patients with steroid-refractory ulcerative colitis

(2011) Haruhiko Ogata et al.   INFLAMMATORY BOWEL DISEASES

Cyclosporine, tacrolimus and sirolimus retain their distinct toxicity profiles despite low doses in the Symphony study

(2010) H. Ekberg et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

Renal function and cardiovascular risk profile after conversion from ciclosporin to tacrolimus: prospective study in 80 liver transplant recipients

(2009) S. BECKEBAUM et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS